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R wave. For LBBB patients, however, there was substantial variability. In 45% of the
cases (15 of 33), the R wave did not coincide with onset of atrial motion.
Conclusion: In patients with a normal ECG, the onset of atrial motion has a predictable
relation with the R wave. In LBBB, this relationship is variable owing to QRS morphology
and electromechanical heterogeneity. In LBBB, atrial motion can be used to determine
time/degree zero because its union with the onset of systole is obligatory and because
EPI can reliably detect it. Setting the onset of the cardiac cycle to an "atriophasic" refer-
ence standard should prove useful in situations where the ECG is an unsuitable timing
signal.
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1133-154 Coronary Artery Magnetic Resonance Angiography 
Comparison of High Field Magnetic Resonance Imaging 
at 1.5 and 3 Tesla
Henning Steen, Joao A. C. Lima, Evangelos Giannitsis, Hugo A. Katus, Matthias Stuber, 
Johns Hopkins Hospital, Baltimore, MD, Universitätsklinikum, Klinik III, Heidelberg, 
Germany
Background:
Cardiac MRI examinations are currently performed at 1.5T. Yet, 3T MRI systems have
recently been approved for human use by the FDA. We compared objective and subjec-
tive parameters for coronary MRA image performance at both 1.5T and 3T.
Methods:
Twelve healthy adult subjects were scanned within one week on both a 1.5 and 3T whole
body scanner (Philips Intera) with an ECG and navigator gated fat suppressed T2 prep
3D gradient coronary MRA- (TR=8.2ms; TE=2.4ms, FOV=360; 512 matrix, 20 slices a
1.5mm, voxel-size= 0.7/1.0/3 mm) sequence. LAD and RCA vessel sharpness / diame-
ters were analysed semi-automatically. Fat saturation-, image quality and motion arte-
facts were assessed via consensus reading (1-4= poor to excellent image quality) and
evaluated using a two-tailed paired Student´s t-test.
Results:
On both scanners LAD and RCA coronary MRA could be successfully obtained. Vessel
sharpness was significantly improved at 3T (RCA: 63.24±0.24 vs. 40.77±0.04; LAD:
42.19±0.08 vs. 33.25±0, 04; both p<0.05) with insignificant difference in diameter com-
parison (RCA 1,5T= 2,85±0,24mm vs. 2,94±0,26 at the 3T; LAD at 1,5T= 2,96±0,27 vs.
2,81±0,25 at 3T). Fat saturation-, image quality and motion artefacts were not signifi-
cantly different.
Discussion:
Three Tesla Coronary MRA results in an objectively improved vessel sharpness and
diameter assessment when compared to 1.5T, while subjective parameters as navigator
and fat saturation performance were not affected by using higher magnetic field strength. 
1133-155 Phase Velocity Mapping by Cardiac Magnetic 
Resonance Is a Valuable Noninvasive Tool in the 
Assessment of Patients With Pulmonary Hypertension
Paola Kuschnir, Rafael Salguero, Javier Sanz, Teresa Rius, Roxana Sulica, Valentin 
Fuster, Michael Poon, Mount Sinai School of Medicine, New York, NY
Background: Advanced pulmonary hypertension is a disease with very poor prognosis.
Right heart catheterization (RHC) is currently the gold standard for its diagnosis. Phase
velocity mapping (PVM) by cardiac magnetic resonance (CMR) is a well-established
method to quantify pulmonary artery (PA) flow velocities. The purpose of our study was
to assess the correlation between hemodynamic data obtained by PVM with RHC.
Methods: 20 consecutive patients were referred for pulmonary hypertension evaluation
with CMR. Right ventricle ejection fraction was assessed by prospective triggered fast
imaging with steady-state precession sequence. PVM of PA was acquired with a breath-
hold, 2D segmented gradient-echo fast low-angle shot pulse sequence with retrospective
cardiac gating. All patients underwent RHC within one week to assess mean PA pressure
(MPAP, mmHg), right atrium pressure, PA saturation, PA vascular resistance index and
cardiac output by thermodilution. Correlations between PVM and RHC hemodynamics
were performed with Pearson’s linear coefficient. Cardiac output results were compared
with paired t-test.
Results: Average PA flow velocity (APV, cm/s) by PVM showed very good correlation
with MPAP (r=-0.86). APV values over 15 were found in all patients with MPAP under 25
(n=5). AVPAFV results between 10-15 were observed in those (n=6) with MPAP between
25-45 except one with an APV values of 9.85. APV values under 10 were found in all
patients (n=9) with MPAP>=45 except in one with an APV value of 10.03. APV value also
showed good correlation with PA vascular resistance index (r=-0.87), right ejection frac-
tion (r=0.83) and PA saturation (r=0.61). No significant correlations were observed for
peak PA flow velocity and forward volume by PVM with RHC data. Cardiac output (L/min)
assessed by PVM (5.34+/-1.50) was significantly lower than by RHC (6.28+/-
2.13)(P=0.047, r=0.45). The use of background suppression does not affect the results
significantly.
Conclusions: PVM can be clinical useful in the initial and follow-up evaluation of patients
with pulmonary hypertension. APV as assessed by PVM shows good correlation with
most RHC data and may be used as a non-invasive parameter in these patients.
1133-156 Results of Four Multicenter, Phase III, Magnetic 
Resonance Angiography (MRA) Trials With MS-325, a 
Blood Pool Contrast Agent, for the Detection of 
Vascular Disease in the Aortoiliac, Renal, and Pedal 
Regions
Emile R. Mohler, III, The MS-325-12/-13/-14/-15 Trial Investigators, University of 
Pennsylvania, Philadelphia, PA, EPIX Medical, Cambridge, MA
Background: To evaluate the safety and efficacy of MS-325 for contrast enhanced (CE)
MRA in the Aortoiliac, Renal, and Pedal arteries as compared to non-contrast 2D-TOF
MRA, using catheter angiography (XRA) as the standard of reference (SOR) in adult
patients with known or suspected arterial occlusive disease.
Methods: Patients received a 0.03 mmol/kg IV bolus of MS-325, an investigational MRI
blood pool contrast agent. In each study, two independent blinded readers interpreted all
XRA images for the presence of clinically significant (>50%) stenosis, with a third reader
independently reading in case of disagreement, in order to establish the SOR. Three dif-
ferent independent blinded readers separately interpreted 2D-TOF and CE-MRA image
sets. Sensitivity, specificity, and accuracy of diagnosis were evaluated for each blinded
reader. Vessels deemed uninterpretable in MRA were considered inaccurate. Inter-
reader XRA agreement was estimated by comparing the results of the two XRA readers.
Patient safety parameters were monitored for 72-96 hours post injection.
Results: Over the four trials, 641 patients and 3404 vessels were evaluated. On average,
MRA readers showed absolute improvements in sensitivity, specificity, and accuracy of
16.4%, 14.6%, and 13.9%, respectively with the application of MS-325. Each reader
showed improvement in accuracy; these improvements were statistically significant in 11/
12 readers. MS-325 gave significant improvements in specificity in all readers; the renal
and aortoilliac readers also showed significant sensitivity improvements. These values
for MS-325-enhanced MRA were comparable to that of XRA inter-reader agreement.
Rates of uninterpretable vessels were 1.6% in CE-MRA, 15.1% for TOF-MRA, and 9.5%
for XRA. Studies yielded consistent safety results: overall AE rate possibly or probably
related to MS-325 was 21%, of those, the majority (96%) were mild or moderate in sever-
ity. No adverse trends in lab chemistries or ECG results were observed.
Conclusion: In 4 Phase III studies, MS-325 was demonstrated to be safe and effective
for the MRA assessment of vascular disease in multiple vascular territories.
1133-157 Effect of Serum Cholesterol Levels on Coronary 
Vasoreactivity in Patients With Type II Diabetes Mellitus
Olakunle O. Akinboboye, Yi Wang, Khurram Moin, Sunil Mathew, Kathy McGrath, 
Margurite Roth, Dwaraka Pollepalle, Raplh Dim, Nathaniel Reichek, Saint Francis 
Hospital, Roslyn, NY
Introduction: Coronary endothelial function is often impaired in patients with diabetes
mellitus (DM). However the determinants of endothelial function in patients with DM have
not been clearly defined. e assessed the magnitude and determinants of myocardial
blood flow response to cold-pressor testing (CPT) using first-pass contrast-enhanced
MRI.
Methods: Twelve patients (5 females, mean age 59 ± 9 with DM but without overt CAD,
underwent MRI first-pass perfusion study at rest and following CPT). Imaging was per-
formed on a 1.5 T Siemens Sonata scanner (Siemens Medical Solutions, Malvern, PA),
using TurboFLASH sequence with the following parameters TR/TE/TI/FA/contrast dose/
data matrix/spatial resolution = 2.9ms/1.3ms/90ms/6°/0.05 mmol/kg/128x70/
3.5x1.9x8mm3. Using MEDIS software (Medis Imaging Systems Inc, The Netherlands),
the steepness of the first pass myocardial signal intensity curve's upslope, normalized to
blood pool upslope (relative upslope) with CPT was divided by corresponding baseline
measurement to calculate myocardial perfusion reserve index (MPRI). In addition the fol-
lowing serum assays were measured: total cholesterol (T chol), triglycerides (trig), HDL
cholesterol (HDL), LDL cholesterol (LDL), Fasting blood glucose (FBS), C-reactive pro-
tein (CRP), insulin, hemoglobin A1c (H-A1c), and Von-Willebrand factor (VWF). Urinary
microalbumin level (µalb), weight (Wt) and waist circumference (WC) were also mea-
sured.
Results: Mean weight 163 ± 55 lbs, µalb: 23 ± 32 mg/dl, WC= 106 ± 9 cm, Tchol= 192 ±
41, Trig = 177 ± 107 mg/dl, HDL= 42 ± 11 mg/dl , LDL= 114 ± 32 mg/dl, FBS = 148 ± 43
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mg/dl, CRP 4.7 ± 3 mg/dl, insulin 12 ± 3 mg/dl, H-A1c 7 ± 1%, VWF = 109 ± 57%, µalb
23 ± 32 mg/dl.
Baseline relative upslope= 9.6 ± 3.4, CPT relative upslope=11.8 ± 3.5 (p = 0.01 for CPT
vs baseline relative upslope). MPRI = 1.24 ± 0.36.Of the variables tested, the significant
correlates of MPRI were: total cholesterol : r = - 0.77 (p = 0.005)and LDL r = - 0.73, p =
0.01). Conclusion: The magnitude of the vasodilatory response to cold-pressor
stimulation in patients with DM is approximately 24% and it is inversely related to
serum total cholesterol and LDL- cholesterol levels.
1133-158 Evaluation of Myocardial Ischemia by Magnetic 
Resonance Myocardial Stress Perfusion in Renal 
Transplant Candidates: Comparison With SPECT and 
Coronary Angiography
Joalbo M. Andrade, Carlos E. Rochitte, Luiz H. Gowdak, Flávio J. Paula, Maria C P 
Giorgi, José R. Parga, Luiz F. Ávila, José A F Ramires, José J G Lima, Heart Institute 
(InCor), University of São Paulo Medical School, São Paulo, Brazil
Introduction: Myocardial first-pass perfusion imaging by magnetic resonance (MPI) dur-
ing pharmacological stress has been shown to detect CAD and to have good correlation
with coronary angiography (CA) and nuclear medicine (NM). However, there are few data
on MPI in specific subgroups of pts, as renal transplant candidates (RTC). In this pts,
noninvasive diagnosis of CAD has been shown to be a challenge by traditional methods.
The aim of this study was to determine the efficacy of stress MPI in the detection of sig-
nificant CAD in high-risk RTC.
Methods: Fifty-two pts, 41 males, mean age 58.1 years, were studied with stress SPECT
sestamibi-Tc99m and MPI. Pts were referred for CA as pre-surgical evaluation. High-risk
for CAD was defined by at least one of the criteria: insulin-dependent DM; age > 50
years; history of angina or congestive heart failure; and abnormal ECG (excluding LV
hypertrophy). MPI was performed on a 1.5T Signa CV/i GE system with parameters: TR
6.3ms, TE 1.2ms, matrix 128x128, and FOV 34-38cm. Dipyridamole dose was 0.56mg/
kg/4min IV. Gadolinium dose was 0.05mmol/kg IV, injected at a 5ml/sec rate. MPI were
analyzed visually by 2 observers blinded to the CA and SPECT results. Abnormal MPI
was based on the presence of myocardial perfusion defect. Significant CAD was defined
as CA with at least one main coronary artery branch with an obstructive lesion > 50%.
Sensitivity, specificity, and accuracy were defined for MPI and SPECT using CA as the
reference method.
Results: Prevalence of significant CAD by CA was 63.5% (33/52). NM showed a sensi-
tivity, specificity, accuracy, positive and negative predictive values of 50.0%, 84.2%,
62.7%, 84.2%, and 50.0%, respectively. MPI had a sensitivity, specificity, accuracy, posi-
tive and negative predictive values of 69.7%, 84.2%, 75.0%, 88.5, and 61.5%, respec-
tively. Although, the results confirm that noninvasive diagnosis of CAD on this group of
pts remains a difficult task, MPI sensitivity and accuracy for detection of significant CAD
was better than SPECT.
Conclusions: This is the first investigation comparing MPI and SPECT in high-risk RTC.
MPI is a usefull alternative to evaluate high-risk RTC and can contribute to the pre-surgi-
cal evaluation of RTC.
1133-159 Comparison of Individually Adapted Breath-Hold and 
Free-Breathing Coronary Magnetic Resonance 
Angioplasty Using Steady State Free Precession
Cosima Jahnke, Ingo Paetsch, Rolf Gebker, Bernhard Schnackenburg, Axel Bornstedt, 
Eckart Fleck, Eike Nagel, German Heart Institute, Berlin, Germany
Background: Flow independent steady state free precession (SSFP) sequences improve
coronary artery visualization in comparison to previous techniques. We assessed the
influence of free-breathing, navigator-gated (NAV) versus breath-hold (BH) technique on
the image quality of SSFP coronary MRA using an identical spatial resolution.
Methods: 40 patients with suspected coronary artery disease underwent MR imaging of
the left or right coronary artery using SSFP (TR/TE/flip: 4.5ms/2.3ms/90°; Philips Intera
CV 1.5T) twice. Correction of breathing motion was done once with real time prospective
navigator and again with BH. The patients BH capability was individually determined and
the duration of data acquisition was adapted using different SENSE-factors. The follow-
ing quantitative parameters were determined: visual score, vessel sharpness, visible ves-
sel length, number of visible side branches. Diagnostic accuracy was calculated in
comparison to invasive x-ray angiography.
Results: With NAV more coronary artery segments yielded interpretable results (84% vs
62%*) and 13% more coronary segments were correctly diagnosed resulting in a signifi-
cantly higher diagnostic accuracy (89.0% vs 79.7%*). In addition, the quantitative param-
eters for image quality showed a significant superiority of the NAV approach (*p<0.05).
Conclusions: Free-breathing, navigator corrected coronary MRA is superior to breath-
holding regarding image quality and diagnostic accuracy of stenosis detection. 
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836-2 Diagnostic Utility of Contrast Enhanced Magnetic 
Resonance Imaging for Screening Patients at Risk for 
Sudden Cardiac Death
Igor Klem, Jonathan Weinsaft, John F. Heitner, Manesh Patel, Annalisa Crowley, Tristram 
Bahnson, Robert M. Judd, Raymond J. Kim, Duke University Medical Center, Durham, 
NC
Background: Invasive electrophysiologic study (EPS) is used to risk stratify patients
(pts) for sudden cardiac death (SCD). Myocardial scar provides an anatomic substrate for
monomorphic ventricular tachycardia (MVT). We evaluated whether the absence of myo-
cardial scar on contrast enhanced MRI (ceMRI) could risk stratify pts by identifying those
without inducible MVT on EPS.
Methods: Cine and ceMRI were performed in pts undergoing clinical EPS to determine
SCD risk. Hyperenhancement on ceMRI was interpreted as scar tissue. EPS results
were classified as high risk if sustained MVT was inducible.
Results: MRI was performed in 58 consecutive pts (29 with known CAD, age 56.1+/-
15.5, 64% male). EPS identified 18 pts at high risk for SCD (MVT +, cycle length 290 +/-
49 msec). 27 pts were non-inducible, 10 had polymorphic ventricular tachycardia, 3 had
idiopathic ventricular tachycardia. ceMRI identified 22 pts (38%) without myocardial scar,
none of these pts had inducible MVT. All patients with inducible MVT demonstrated MRI
evidence of scar. Multivariate regression analysis found that scar size was the strongest
independent predictor of MVT inducibility (p=0.03), and that LV ejection fraction showed
a trend towards significance (p=0.07) (see table).
Conclusions: Patients undergoing EPS often do not have myocardial scar on ceMRI.
ceMRI demonstrates high negative predictive value for inducible MVT and should be con-
sidered as a screening test in the diagnostic work-up of pts at risk for SCD prior to inva-
sive EPS.
11:00 a.m.
836-3 The Limits of Quantifiable Differences in Dipyridamole 
Stress Magnetic Resonance Imaging Perfusion Defects 
in Human Subjects With Coronary Artery Disease
Kenneth L. Rhoads, Li-yueh Hsu, W. Patricia Ingkanisorn, Christopher K. Dyke, 
Mushabbar A. Syed, Preeti Kansal, Anthony H. Aletras, Andrew E. Arai, National 
Institutes of Health, Bethesda, MD
Background: A dual-bolus first-pass MRI quantitative perfusion technique can evaluate
absolute myocardial blood flow where a low concentration bolus defines the input func-
tion and a high concentration bolus provides strong myocardial enhancement. We deter-
mined the limits with which MRI myocardial perfusion can be quantified and evaluated
the feasibility of dual-bolus perfusion analysis in humans.
Methods: Perfusion analysis limits were tested: 1) by measuring the coefficient of varia-
tion of myocardial blood flow (MBF) in 10 normal volunteers; and 2) by measuring perfu-
sion in 20 patients in: a) normal myocardium; b) regions with >70% stenosis by
quantitative coronary angiography but without infarction (MI); c) regions of MI with >70%
stenosis; and d) regions of MI without stenosis. Feasibility was tested in 64 patients and
10 normal subjects by assessing time intensity curve quality. Dipyridamole (0.56 mg/kg)
stress utilized a dual-bolus first pass perfusion technique [Gadolinium-DTPA 0.005 and
0.1 mmol/kg] on a GE 1.5 T CV/i scanner and Fermi function deconvolution. Cine MRI
and delayed hyperenhancement imaging were also performed.
Results: Limits in Normal Volunteers: Perfusion averaged 4.45+/-1.12 ml/min/g with
stress and 2.06+/-0.56 ml/min/g at rest (p<0.001). The coefficient of variation for six seg-
ments averaged 8% during stress and 7% at rest. Limits in Patients: Relative to a normal
segment, infarcted segments without residual stenosis had 75% as much MBF (p=0.01),
segments with stenosis but no MI had 61% as much MBF (p<0.001), and segments with
both stenosis and MI had 44% as much MBF (p<0.001). The sensitivity for a >70%
Predictors of MVT Inducibility
Variable Univariate Coefficient 
+/- S.E.
p value Multivariate 
Coefficient +/- 
S.E.
p value
Age 0.03 +/- 0.02 0.13 - -
Male 0.55 +/- 0.62 0.33 - -
CAD 2.23 +/- 0.71 0.002 - -
Aneurysm 2.41 +/- 1.16 0.04 - -
QRS Duration 0.02 +/- 0.01 0.07 - -
LV EF -0.08 +/- 0.02 0.001 -0.05 +/- 0.03 0.07
% LV Hyperenhancement 0.10 +/- 0.03 0.001 0.07 +/- 0.03 0.03
